Supreme Court rejects appeals brought by anti-vaccine group founded by RFK Jr over Covid injections
Independent presidential candidate Robert F. Kennedy Jr. speaks during a campaign rally at the Legends Event Center on December 20,…
Health
Discover the Latest Health, Medicine, Nutrition, and Fitness Tips for Women, Men, and Children
FDA approves first menthol e-cigarettes, citing potential for adult smokers
The Food and Drug Administration on Friday authorized the first menthol-flavored e-cigarettes for adult smokers, recognizing that vaping flavors can…
Eli Lilly expects FDA to apply for Zepbound for sleep apnea in the short term
Eli Lilly On Friday it said it applied for U.S. approval of its weight-loss drug Zepbound for the treatment of…
Paradromics prepares to test its brain implant in humans
Neurotech startup Paradromics will test its brain implant next year, as the race to be a leader in the nascent…
Our reporter on how pharmacy benefit managers work
Pharmacy benefit managers are driving up drug costs for millions of people, employers, and the government. New York Times pharmaceutical…
Being born in a war zone: coping with continued attacks in Ukraine
The couple had gone to maternity hospital number 5 in the port city of Odessa, in southern Ukraine. The center…
WHO announces global resurgence of cholera cases in 2024
The agency's Eastern Mediterranean Region reported the highest number of cases, followed by the Africa Region, the Americas Region, the…
UN health agency issues alert on counterfeit medicines used to treat diabetes and weight loss
The spurious semaglutides, of a specific brand Ozempic, were found in Brazil, the United Kingdom in October 2023 and the…
Catalyst Calendar: Here's a Look at the Major Events That Could Drive These 7 Stocks Higher
AI technology stocks have been all the rage on Wall Street. But here are some events that could boost other…
Gilead PrEP lenacapavir succeeds in phase 3 trial
The logo of the pharmaceutical company Gilead Sciences in Oceanside, California, on April 29, 2020. Mike Blake | Reuters GileadThe…